Soc. Generale Bonus Zert MRK 28.0.../ DE000SU1F5Z4 /
2024-05-23 8:23:40 AM | Chg.-2.88 | Bid7:50:04 AM | Ask7:50:04 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
144.61EUR | -1.95% | 147.15 Bid Size: 250 |
148.00 Ask Size: 250 |
MERCK KGAA O.N. | - EUR | 2024-06-28 | Call |
GlobeNewswire
05-23
Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at ...
GlobeNewswire
05-23
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
05-23
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA